search
Back to results

The Comparison of Electronic Auscultation Coupled With CALSA and FRI; Repeatability of FRI Biomarkers

Primary Purpose

Asthma

Status
Withdrawn
Phase
Not Applicable
Locations
Belgium
Study Type
Interventional
Intervention
CT-scan
Sponsored by
FLUIDDA nv
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Asthma

Eligibility Criteria

18 Years - 120 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Male or female patient / volunteer ≥ 18 years old
  • Written informed consent obtained
  • The subject belongs to 1 of the following groups in the opinion of the investigator:

Group 1: healthy volunteer Group 2: patient with asthma

  • Only if patient/ volunteer is a female of childbearing potential: Confirmation that a contraception method was used at least 14 days before visit 1

Exclusion Criteria:

  • Pregnant or lactating female
  • Patient/ volunteer with an uncontrolled disease or any condition that might, in the judgement of the investigator, place the patient at undue risk or potentially compromise the results or interpretation of the study.

Patient/ volunteer with an uncontrolled disease or any condition that might, in the judgement of the investigator, place the patient at undue risk or potentially compromise the results or interpretation of the study.

Sites / Locations

  • Antwerp University Hospital

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

CALSA and FRI repeatability

Arm Description

CT-Scan No medication used

Outcomes

Primary Outcome Measures

CALSA
The primary objective of this study is to compare CALSA with FRI. The respiratory sounds recordings are performed with a digital stethoscope and connected to the sound card of a laptop with commercial software, suitable for data acquisition. The respiratory sounds recordings are conducted in accordance with the Computerized Respiratory Sound Analysis guidelines (CORSA) for short-term acquisition. Subjects are asked to breathe through the mouth in a sitting position (tidal breathing) during the recordings. Three sets of recordings are made for 7 - 10 respiratory cycles with a maximum duration of 25 seconds.

Secondary Outcome Measures

Total Airway Volume (iVaw)
The secondary objective is to check the repeatability of the FRI parameters
Total Airway Resistance (iRaw)
The secondary objective is to check the repeatability of the FRI parameters.
Internal Airway Distribution
The secondary objective is to check the repeatability of the FRI parameters
Lobar Volume
The secondary objective is to check the repeatability of the FRI parameters

Full Information

First Posted
August 25, 2014
Last Updated
February 2, 2016
Sponsor
FLUIDDA nv
search

1. Study Identification

Unique Protocol Identification Number
NCT02228018
Brief Title
The Comparison of Electronic Auscultation Coupled With CALSA and FRI; Repeatability of FRI Biomarkers
Official Title
The Comparison of Electronic Auscultation Coupled With Computer Aided Lung Sound Analysis (CALSA) and Functional Respiratory Imaging (FRI) and Repeatability of FRI Biomarkers in Healthy Subjects and Asthma Patients
Study Type
Interventional

2. Study Status

Record Verification Date
January 2016
Overall Recruitment Status
Withdrawn
Why Stopped
Other strategies followed
Study Start Date
March 2015 (undefined)
Primary Completion Date
January 2016 (Anticipated)
Study Completion Date
January 2016 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
FLUIDDA nv

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
CALSA will be compared with FRI and the repeatability of the FRI parameters will be tested in a group of healthy volunteers and asthma patients.
Detailed Description
his is a study with no investigational product. CALSA will be compared with FRI and the repeatability of the FRI parameters will be tested in a group of healthy volunteers and asthma patients. Electronic auscultation of respiratory sounds will be performed, lung function tests (at maximal dilatation) will be executed and computed tomography (CT) scans of the thorax will be taken. The scans will be taken at two different breathing levels, more specifically at total lung capacity (TLC) and functional residual capacity (FRC) level. The scans will be taken while the patient/ volunteer lies down on the movable table of the CT-scan. After the scan is taken it will be asked to the patient/ volunteer to sit upright on the scanning table and to lie down again. When the patient/ volunteer lies down a second CT-scan (TLC and FRC) will be taken. The objective of this study is to compare CALSA with FRI and to assess the repeatability of FRI biomarkers

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Asthma

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
0 (Actual)

8. Arms, Groups, and Interventions

Arm Title
CALSA and FRI repeatability
Arm Type
Experimental
Arm Description
CT-Scan No medication used
Intervention Type
Device
Intervention Name(s)
CT-scan
Intervention Description
CT-Scan will be taken at visit 1 on FRC and TLC breathing levels
Primary Outcome Measure Information:
Title
CALSA
Description
The primary objective of this study is to compare CALSA with FRI. The respiratory sounds recordings are performed with a digital stethoscope and connected to the sound card of a laptop with commercial software, suitable for data acquisition. The respiratory sounds recordings are conducted in accordance with the Computerized Respiratory Sound Analysis guidelines (CORSA) for short-term acquisition. Subjects are asked to breathe through the mouth in a sitting position (tidal breathing) during the recordings. Three sets of recordings are made for 7 - 10 respiratory cycles with a maximum duration of 25 seconds.
Time Frame
1 day
Secondary Outcome Measure Information:
Title
Total Airway Volume (iVaw)
Description
The secondary objective is to check the repeatability of the FRI parameters
Time Frame
1 day
Title
Total Airway Resistance (iRaw)
Description
The secondary objective is to check the repeatability of the FRI parameters.
Time Frame
1 day
Title
Internal Airway Distribution
Description
The secondary objective is to check the repeatability of the FRI parameters
Time Frame
1 day
Title
Lobar Volume
Description
The secondary objective is to check the repeatability of the FRI parameters
Time Frame
1 day

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
120 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Male or female patient / volunteer ≥ 18 years old Written informed consent obtained The subject belongs to 1 of the following groups in the opinion of the investigator: Group 1: healthy volunteer Group 2: patient with asthma Only if patient/ volunteer is a female of childbearing potential: Confirmation that a contraception method was used at least 14 days before visit 1 Exclusion Criteria: Pregnant or lactating female Patient/ volunteer with an uncontrolled disease or any condition that might, in the judgement of the investigator, place the patient at undue risk or potentially compromise the results or interpretation of the study. Patient/ volunteer with an uncontrolled disease or any condition that might, in the judgement of the investigator, place the patient at undue risk or potentially compromise the results or interpretation of the study.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Wilfried De Backer, MD, PhD
Organizational Affiliation
University Hospital, Antwerp
Official's Role
Principal Investigator
Facility Information:
Facility Name
Antwerp University Hospital
City
Edegem
State/Province
Antwerp
ZIP/Postal Code
2650
Country
Belgium

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

The Comparison of Electronic Auscultation Coupled With CALSA and FRI; Repeatability of FRI Biomarkers

We'll reach out to this number within 24 hrs